CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 133 enrolled
Drug / intervention
CONTROL +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03228212
NCT03228212N/ACompleted
CompareCT.gov

Evaluation of Approved and Investigational Contact Lenses

Johnson & Johnson Vision Care, Inc.·interventional·Posted Jul 24, 2017·Updated Dec 13, 2018

In Brief

A clinical study evaluating CONTROL and TEST for Visual Acuity. Completed, enrolled 133 participants across 5 sites.

Detailed Summary

This study is a randomized, 5-visit, partial subject masked, 2x3 bilateral crossover, dispensing clinical trial. During the study, each test article will be worn in a daily wear modality for at least 6 hours per day and 5 days per week for approximately 2 weeks each. The subject will wear either the Test or Control article twice and the other study article once. The primary objective of this study is to demonstrate that the Test lens works as well, if not better compared to the Control lens with respect to CLUE (Contact Lens User Experience) comfort, Slit Lamp findings, and Distance Monocular logMAR Visual Acuity. This study will also aim to show acceptable lens fit for subjects wearing the Test lens.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJul 24, 2017
Enrollment StartJul 14, 2017
Primary CompletionSep 18, 2017
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 8.9 years ago

Interventions

CONTROLdevice

ACUVUE OASYS

TESTdevice

senofilcon A with new UV blocker